Held · Bookmarked
0 · 0
portfolios · users
Avg position size
—
of holders' portfolios
13F filers
1
institution
Market cap
$8.4M
5M shares
52-week range
$1.41 – $6.24
2% from low
Sector
AGRICULTURAL CHEMICALS
Exchange
NASDAQ
CS
Borrow rate
1.89%
Moderate
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $297.0K | $143.0K | $258.0K | $576.0K | $1.0M | $1.2M | $1.9M | $2.2M |
| Cost of revenue | $241.0K | $101.0K | $281.0K | $356.0K | $555.0K | $654.0K | $853.0K | $833.0K |
| Gross profit | $56.0K | $42.0K | −$23.0K | $220.0K | $464.0K | $539.0K | $1.0M | $1.4M |
| Gross margin | 18.9% | 29.4% | -8.9% | 38.2% | 45.5% | 45.2% | 54.1% | 62.5% |
| R&D | $2.4M | $1.9M | $1.5M | $2.0M | $1.9M | $1.2M | $1.7M | $1.7M |
| Operating income | −$11.9M | −$10.3M | −$7.9M | −$8.9M | −$9.7M | −$7.7M | −$6.2M | −$6.5M |
| EBITDA | −$11.4M | −$9.6M | −$7.6M | −$8.0M | −$9.5M | −$7.6M | −$6.0M | −$6.2M |
| Net income | −$11.9M | −$10.0M | −$7.9M | −$8.3M | −$9.7M | −$7.7M | −$6.2M | −$6.4M |
| Net margin | -4009.4% | -7005.6% | -3076.4% | -1435.4% | -951.4% | -646.3% | -333.0% | -287.4% |
| EPS (diluted) | -30283.00 | -18457.00 | -6683.98 | -1773.00 | -1860.00 | -115.10 | -8.86 | -1.95 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $2M | $-1.48 | $-1.79–$-1.17 | 1 |
| 2027 | $4M | $-1.25 | $-1.42–$-1.06 | 2 |
| 2028 | $13M | $-0.67 | $-0.81–$-0.53 | 1 |
| 2029 | $21M | $0.10 | $0.08–$0.12 | 1 |
Forward consensus · source: Financial Modeling Prep
SenesTech Inc is a United States-based biotech platform and research company engaged in developing technology for managing animal pest populations through fertility control. The company has developed and are commercializing products for managing animal pest populations through fertility control and population management strategies. Its current products focus on rat and mouse populations, and are known as: ContraPest, Evolve Rat, and Evolve Mouse.
www.senestech.comNo one on the platform currently holds SNES.
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2026-03-31 | 114,000 | $187.0K |
| Execution date | Ratio |
|---|---|
| 2024-07-25 | 1-for-10reverse |
| 2023-11-17 | 1-for-12reverse |
| 2022-11-16 | 1-for-20reverse |
| 2022-09-01 | 2-for-1 |
| 2020-02-05 | 1-for-20reverse |
No one on the platform has traded SNES yet.
| $1M |
| — |
| ELBMElectra Battery Materials Corporation | $0.60 | +14.03% | $63M | — |
| GUREGulf Resources, Inc. | $3.68 | -6.24% | $6M | — |
Source: Financial Modeling Prep · peers by sector/industry
$SNES https://www.prnewswire.com/news-releases/senestech-appoints-jack-karabees-as-executive-vice-president-of-sales-302812733.html
View on StockTwits ↗$SNES The same grift they have doing for years. Wake up people. You are getting ripped off in broad daylight. I’ve been warning folks for several years.
View on StockTwits ↗$SNES More buys from Glenbrook Capital. Genius or Death Wish? We'll see. Overdue for some good news. New Zealand or Australia would be nice.
View on StockTwits ↗$SNES Hantavirus Quarantine Ends, as Outbreak Underscores Need to Control Rodent Populations https://buff.ly/bE4M0UN
View on StockTwits ↗$SNES 0800 NO RATS https://www.theguardian.com/world/2026/jun/17/rat-hunters-catchers-predator-free-new-zealand-wellington-rats-problem
View on StockTwits ↗$SNES SenesTech held its annual shareholder meeting on June 9, 2026. Shareholders backed an amendment to the 2018 Equity Incentive Plan, increasing the share pool by 1.2 million; the vote authorizes the change. Shareholders ratified M&K CPAS, PLLC as independent registered public accounting firm for the year ending Dec. 31, 2026
View on StockTwits ↗$SNES nothing new to see here. Another loser of a day.
View on StockTwits ↗$SNES Chemical rodenticides are facing tighter regulations. Rodent resistance to traditional methods is growing. SenesTech takes a different approach, targeting reproduction instead of relying on poison. #SmallCap #Investing #PestManagement youtu.be/rhhQcbDzgoE
View on StockTwits ↗$SNES Capital Management raised its stake in SenesTech to 954,144 shares through open-market purchases. The buying totaled 28,389 shares at prices ranging from $1.57 to $1.65 per share. SenesTech CEO Michael Edell bought 1,000 common shares at $1.55. His direct holdings rose to 4,000 shares.
View on StockTwits ↗$SNES 08:08 on Jun. 04 2026 SenesTech Expands Evolve Rodent Birth Control Products Into Bermuda Through Distribution Agreement With Animal And Garden House #tradeideas
View on StockTwits ↗Hantavirus Ship Shines Light on Problem $SNES Tackles – Initiating Coverage https://buff.ly/vtvikke
View on StockTwits ↗$SNES they have no debt too ! I'm sure they will be successful with the focus on the D2C angle, new website coming soon too I got told. Anyone in with me ?
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.
Click to see transaction details on SEC.gov. Form 4s cover trades by officers, directors, and 10%+ owners, due within 2 business days of the trade.
Trading at 0.4× sales vs its 8.4× historical median P/S.
Fair value ≈ $31.33 · price $1.51 today
Fair-value line = the stock's median historical P/S × sales per share. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.